Shorts

0:32

Can Psychiatric Medications Worsen Stuttering?

2 months ago

Gerald A. Maguire, MD

2:10

AI and Clinical Prediction Models

2 months ago

Joseph F. Goldberg, MD(+1 more)

1:45

Importance of Cultural Awareness in Psychiatric Care

2 months ago

Frank A. Clark, MD(+1 more)

1:30

Remission Rates in the First 2 Weeks of Treatment

2 months ago

Lara Shirikjian, MD

0:55

The Explosion of Alzheimer's Drug Research

2 months ago

Oleg Tcheremissine, MD

1:32

Breaking Mental Health Stigma in Communities of Color

2 months ago

Frank A. Clark, MD(+1 more)

1:25

Switching ADHD Medications Effectively

2 months ago

Raman Baweja, MD

0:30

Can Sleeping Pills Treat Alzheimer Disease?

2 months ago

Tri Doan, MD, PhD

0:43

Why Sleep Is Critical for Psychiatric Health

2 months ago

Tri Doan, MD, PhD

1:26

Targeting Sleep Quality in Depression

2 months ago

Gregory Sullivan, MD

0:30

Why ADHD Meds Don't Always Help Mood Swings

2 months ago

Lenard A. Adler, MD

0:37

The Math Behind Patient Benefits in Clinical Trials

2 months ago

Oleg Tcheremissine, MD

0:42

How Genetics and Sleep Quality Predict Early Alzheimer Disease

2 months ago

Tri Doan, MD, PhD

0:48

New ADHD Treatment: Beyond Stimulants

2 months ago

Lenard A. Adler, MD

0:31

Why We Need Expanded Access

2 months ago

Oleg Tcheremissine, MD

1:37

Seltorexant vs Quetiapine Adjunct for MDD

2 months ago

Jane Tiller, MD

0:46

What Makes This ADHD Drug Potentially Unique

2 months ago

Lenard A. Adler, MD

0:41

The Biggest Challenge in Treating Alzheimer Disease

2 months ago

Oleg Tcheremissine, MD

0:52

Morning Coffee and Updates: The Approval of Centanafadine for ADHD

2 months ago

Leah Kuntz

1:06

Impact of Placebo & Patient Expectations on Medication Outcomes

2 months ago

Joseph F. Goldberg, MD(+1 more)

0:43

Is Alzheimer Disease Actually Type 3 Diabetes?

2 months ago

Oleg Tcheremissine, MD

1:30

Late Responders in Long Term Treatment With Austedo for Tardive Dyskinesia

2 months ago

Verena Ramirez-Campos, MD

1:15

The Placebo Effect at Work in Psychopharmacology

2 months ago

Joseph F. Goldberg, MD(+1 more)

1:34

FDA Approves Centanafadine: A New Frontier in ADHD Treatment

2 months ago

Ann Childress, MD

1:33

Expanding the Neurotransmitter View of Depression

3 months ago

Jason Kellogg, MD

1:16

Discussing LAIs Candidly With Patients

3 months ago

Gerald A. Maguire, MD

1:50

COMP360, Synthetic Psilocybin, Shows Enduring Benefit

3 months ago

Gustavo Alva, MD, DFAPA

0:53

Financial Barriers to Neuromodulation Access

3 months ago

Jason Kellogg, MD

2:05

Impacts of Tribalism in Psychiatry

3 months ago

John J. Miller, MD(+1 more)

1:09

Mental Health Awareness & Advancing Cholinergic Agents

3 months ago

Carey Martin, DNP, PMHNP

Shorts

Trending on Psychiatric Times

FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia

Interventional Options for TRD: ECT, TMS, and Esketamine

Defining Treatment-Resistant Depression In Adults

Vortioxetine's Effect on Cognitive Function in Older Adults With Major Depressive Disorder

Sexual Dysfunction in Depression: Assessing Pleasure Alongside Desire, Arousal, and Orgasm